J&J, Institute of Microbial Technology deal

Johnson & Johnson (NYSE:JNJ) and Institute of Microbial Technology (Chandigarh, India) partnered to accelerate development of oral treatment regimens to treat multidrug-resistant tuberculosis and to d...